Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Patient Knowledge Base

Is CAR T-cell therapy approved for multiple myeloma?

CAR T-cell therapy is approved for multiple myeloma that has relapsed after or is refractory to at least four previous lines of treatment. The clinical trial shows CAR T-cell therapy to be highly effective for patients whose disease had relapsed after or not responded to multiple prior treatments.

Need Some Help?